New injection aims to protect cancer patients from Chemotherapy's Blood-Thinning danger
NCT ID NCT06521931
Summary
This early-stage study tested a new injection called PN20, given right before chemotherapy, to see if it could safely prevent a dangerous drop in platelets (the cells that help blood clot). It involved 24 adults with lymphoma or solid tumors who had experienced low platelets during prior chemotherapy. The main goal was to check if PN20 was safe and well-tolerated, and to see if it could help keep platelet counts at a safer level.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Hebei University
Baoding, Hebei, 071000, China
-
Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646000, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266057, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 471003, China
-
Yiyang Central Hospital
Yiyang, Hunan, 413099, China
Conditions
Explore the condition pages connected to this study.